Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback